PGRN overexpression was associated with elevated levels of vascular endothelial growth factor (VEGF) through AKT and ERK1/2, contributing to the proliferation of colorectal cancer, breast cancer and oesophageal squamous cell carcinoma cells [92,93]. Here, GRN is linked to breast cancer.